Anion Exchange Chromatography for Full AAV Capsid Enrichment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying adeno-associated virus (AAV) capsids are inefficient, leading to high costs and low yields due to challenges in separating full capsids from empty or partially filled ones, and existing purification techniques struggle to achieve high enrichment of full capsids, which is crucial for therapeutic efficacy.
Innovation Solution
The method involves multiple passes of anion exchange chromatography using microsteps or linear gradients to enrich full AAV capsids, potentially combined with depth filtration and affinity chromatography, reducing the need for endonuclease treatment and optimizing salt concentrations to enhance purification efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If traditional depth filtration is used without endonuclease treatment, then cost is reduced, but filter fouling increases and clarification efficiency decreases
Solution Approach 1:
The patent applies preliminary action by treating the lysate with endonuclease before depth filtration to degrade chromatin DNA. This pre-treatment prevents filter fouling during the filtration step, allowing the process to proceed efficiently without requiring excessive filter area or frequent filter changes, thus resolving the contradiction between cost reduction and maintaining clarification efficiency.
2Measurement precision
If affinity capture is used for surface-modified AAVs, then capture specificity is improved, but conjugated species are lost during purification
Solution Approach 1:
The patent applies parameter changes by optimizing the elution conditions (pH, ionic strength, temperature) to achieve selective elution of full capsids while retaining conjugated species on the column. By carefully controlling these parameters, the method maintains capture specificity for surface-modified AAVs while preventing loss of the valuable conjugated species during the purification process.
Solution Approach 2:
The patent applies dynamics by using a multi-step elution process with gradually changing conditions. The dynamic adjustment of elution parameters allows progressive release of different capsid populations, enabling selective recovery of full capsids while preserving conjugated species that might be released under more stringent conditions.
3Manufacturing precision
If multiple purification steps are used to enrich full capsids, then enrichment factor is improved, but process complexity increases
Solution Approach 1:
The patent applies merging by combining multiple purification techniques (depth filtration, affinity capture, anion exchange chromatography) into an integrated multi-step process. Each step is optimized to work synergistically with the others, achieving high enrichment of full capsids while managing overall process complexity through systematic integration rather than isolated sequential operations.
Solution Approach 2:
The patent applies segmentation by dividing the purification process into distinct functional modules: clarification module, capture module, and enrichment module. Each module performs a specific function and can be independently optimized, which manages complexity while achieving cumulative enrichment effects across the entire process train.
4Manufacturing precision
If endonuclease treatment is applied before depth filtration, then chromatin breakdown is improved, but purification cost increases
Solution Approach 1:
The patent applies parameter changes by optimizing endonuclease treatment conditions (enzyme concentration, incubation time, temperature, pH) to achieve effective chromatin degradation at minimal enzyme dosage. By carefully controlling these parameters, the process achieves sufficient chromatin breakdown to prevent filter fouling while minimizing the amount of expensive endonuclease required, thus resolving the contradiction between degradation efficacy and cost.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves significant enrichment of full capsids, improving the yield and purity of AAV preparations, thereby enhancing the therapeutic potential of AAV-based treatments by minimizing immune responses from non-functional capsids.
Implementation Method 1
subjecting a sample comprising AAV capsids to anion exchange chromatography in a buffer using microsteps or linear gradients to separate full AAV capsids from unfilled capsids
Implementation Method 2
subjecting a first pool from step (a) to depth filtration to form a second pool
Data Source
AI summary
The inventions provide methods of purifying full adeno-associated virus (AAV) capsids, wherein the method comprises the steps of (a) subjecting a sample comprising AAV capsids in buffer to anion exchange chromatography (AEX) to separate full AAV capsids from capsids that are not full (that is, partially-filled AAV capsids, nearly empty AAV capsids and empty AAV capsids) and form a first pool (“first AEX pass”), wherein the first pool is enriched in the ratio of full capsids to capsids that are not full; and (b) subjecting the first pool to anion exchange chromatography to form a second pool (“second AEX pass”), wherein the second pool is further enriched in the ratio of full capsids to capsids that are not full (that is, partially-filled AAV capsids, nearly empty AAV capsids and empty AAV capsids), wherein the enrichment in full capsids can be least 3 fold. Third, fourth and more AEX passes also can be undertaken. Depth filtration, single-pass tangential flow filtration and affinity exchange also can be included in the inventive methods, preferably undertaken prior to AEX. Enriched AAV preparations and drug products also are provided.